Device Trial Radar · NCT04129125
The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
Last checked: Nov 19, 2026Latest source record: Aug 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
328
Actual
Start
Oct 1, 2021
Primary completion
May 28, 2024
Study completion May 28, 2024
Sponsor
- Lead sponsor
- Imperative Care, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 16, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The trial is designed to assess the safety and efficacy of using the Zoom Reperfusion System in subjects diagnosed with acute ischemic stroke and undergoing a thrombectomy procedure within 8 hours of last known well.
Conditions
- Ischemic Stroke
- Acute Stroke
Interventions
Zoom Reperfusion SystemDevice
Thrombectomy
Primary outcomes
What the sponsor says the trial is designed to measure.
- ITT Cohort: Rate of Core Lab-adjudicated Reperfusion SuccessTime frame: Intraprocedural
- ITT Cohort: Rate of Symptomatic Intracranial Hemorrhage (sICH), as Independently Adjudicated by Core Lab and Safety BoardTime frame: 24-hour post-procedure
- FDA Clearance Cohort: Rate of Core Lab-adjudicated Reperfusion SuccessTime frame: Intraprocedural
3 more outcomes with a free account
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Radiology of Huntsville
Huntsville, Alabama
Carondelet Neurological Institute St. Joseph's Hospital
Tucson, Arizona
University of Southern California
Los Angeles, California
25 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.